Value | Eligibility | Open date | Close date |
---|---|---|---|
$42,440 p.a. (up to 3 years) |
|
22 May 2024 | 13 June 2024 |
Apply here.
The Scholarship will provide a stipend allowance of $42,440 per annum for up to 3 years, subject to satisfactory academic performance.
You must:
This Scholarship has been established to provide financial assistance to a PhD student who is undertaking research in problematic literature reviews in molecular cancer research.
This Scholarship is funded by a National Health and Medical Research Council (NHMRC) grant.
For more information about the PRIMeR group and the team's research, please see: https://www.sydney.edu.au/medicine-health/our-research/research-centres/publication-and-research-integrity-in-medical-research-primer.html